C12Y 601/01014
Glycine-trna ligase
Official title: Glycine-tRNA ligase (6.1.1.14)
C12Y601/01014 (Glycine-trna ligase) appears on 11 US grants and 16 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 16
- Assignees
- 12
- Inventors
- 52
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 3 |
| 2014 | 2 | 1 |
| 2015 | 2 | 0 |
| 2016 | 0 | 2 |
| 2017 | 2 | 2 |
| 2018 | 0 | 1 |
| 2019 | 2 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 3 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Fragmented GRS polypeptide and variant thereof, and use thereof16 Jun 2026US 12,655,413 B2Nibec Co., Ltd.
- Modified mussel proteins, uses thereof and related compounds31 May 2022US 11,345,910 B2Technische UniversitäT Berlin
- Nanoparticles comprising aminoacyl tRNA synthetase and anticancer composition comprising same16 Apr 2019US 10,258,674 B2Medicinal Bioconvergence Research Center
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases5 Feb 2019US 10,196,629 B2aTyr Pharma, Inc.
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases24 Oct 2017US 9,796,972 B2aTyr Pharma, Inc.
- Multimeric antibody platform and methods of making and using multimeric antibody platform5 Oct 2023US 2023/0313180 A1Oregon State University
- Products and methods for inhibition of expression of mutant gars protein21 Oct 2021US 2021/0324417 A1Research Institute At Nationwide Children's Hospital
- Fragmented grs polypeptide and variant thereof, and use thereof1 Jul 2021US 2021/0198650 A1Nibec Co., Ltd.
- Modified Mussel Proteins, Uses Thereof and Related Compounds25 Mar 2021US 2021/0087237 A1Technische UniversitäT Berlin
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases14 Jun 2018US 2018/0163194 A1aTyr Pharma, Inc.
Most cited
By later US patents
- Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities71US 8,404,471 B2aTyr Pharma, Inc. · 2013
- Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities11US 8,747,840 B2aTyr Pharma, Inc. · 2014
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases8US 8,999,321 B2aTyr Pharma, Inc. · 2015
- Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities1US 9,157,076 B2aTyr Pharma, Inc. · 2015
- Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities1US 9,585,946 B2aTyr Pharma, Inc. · 2017